Current state of melanoma diagnosis and treatment

LE Davis, SC Shalin, AJ Tackett - Cancer biology & therapy, 2019 - Taylor & Francis
Melanoma is the deadliest form of skin cancer. In the early stages, melanoma can be treated
successfully with surgery alone and survival rates are high, but after metastasis survival …

Clinical applications of quantitative proteomics using targeted and untargeted data-independent acquisition techniques

JG Meyer, B Schilling - Expert review of proteomics, 2017 - Taylor & Francis
Introduction: While selected/multiple-reaction monitoring (SRM or MRM) is considered the
gold standard for quantitative protein measurement, emerging data-independent acquisition …

[HTML][HTML] Next-generation characterization of the cancer cell line encyclopedia

M Ghandi, FW Huang, J Jané-Valbuena, GV Kryukov… - Nature, 2019 - nature.com
Large panels of comprehensively characterized human cancer models, including the
Cancer Cell Line Encyclopedia (CCLE), have provided a rigorous framework with which to …

Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate

AA Chakraborty, T Laukka, M Myllykoski, AE Ringel… - Science, 2019 - science.org
Oxygen sensing is central to metazoan biology and has implications for human disease.
Mammalian cells express multiple oxygen-dependent enzymes called 2-oxoglutarate (OG) …

JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States

LE Stevens, G Peluffo, X Qiu, D Temko, A Fassl, Z Li… - Cancer research, 2023 - AACR
Inflammatory breast cancer (IBC) is a difficult-to-treat disease with poor clinical outcomes
due to high risk of metastasis and resistance to treatment. In breast cancer, CD44+ CD24 …

[HTML][HTML] KDM5 histone demethylase activity links cellular transcriptomic heterogeneity to therapeutic resistance

K Hinohara, HJ Wu, S Vigneau, TO McDonald… - Cancer cell, 2018 - cell.com
Members of the KDM5 histone H3 lysine 4 demethylase family are associated with
therapeutic resistance, including endocrine resistance in breast cancer, but the underlying …

Synthetic lethal and resistance interactions with BET bromodomain inhibitors in triple-negative breast cancer

S Shu, HJ Wu, YG Jennifer, R Zeid, IS Harris… - Molecular cell, 2020 - cell.com
BET bromodomain inhibitors (BBDIs) are candidate therapeutic agents for triple-negative
breast cancer (TNBC) and other cancer types, but inherent and acquired resistance to BBDIs …

Down-syndrome-induced senescence disrupts the nuclear architecture of neural progenitors

HS Meharena, A Marco, V Dileep, ER Lockshin… - Cell Stem Cell, 2022 - cell.com
Down syndrome (DS) is a genetic disorder driven by the triplication of chromosome 21 (T21)
and characterized by a wide range of neurodevelopmental and physical disabilities …

High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC program

DP Labbé, G Zadra, M Yang, JM Reyes, CY Lin… - Nature …, 2019 - nature.com
Systemic metabolic alterations associated with increased consumption of saturated fat and
obesity are linked with increased risk of prostate cancer progression and mortality, but the …

Exploiting the epigenome to control cancer-promoting gene-expression programs

GL Brien, DG Valerio, SA Armstrong - Cancer cell, 2016 - cell.com
The epigenome is a key determinant of transcriptional output. Perturbations within the
epigenome are thought to be a key feature of many, perhaps all cancers, and it is now clear …